Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China · Delayed Price · Currency is CNY 22.99
-0.02 (-0.09%)
Jul 18, 2025, 2:45 PM CST
SHE:002287 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 560.5 | 582.28 | 581.2 | 472.54 | 715.88 | 403.96 | Upgrade |
Depreciation & Amortization | 119.1 | 119.1 | 93.24 | 83.19 | 65.83 | 43.79 | Upgrade |
Other Amortization | 21.26 | 21.26 | 2.53 | 2.72 | 2.08 | 0.05 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -0.32 | -0 | 0.07 | 0.35 | Upgrade |
Asset Writedown & Restructuring Costs | 0.58 | 0.58 | 0.3 | 1.22 | 16.13 | 0.04 | Upgrade |
Loss (Gain) From Sale of Investments | -100.32 | -100.32 | -69.31 | 32.86 | -328.81 | -12.66 | Upgrade |
Provision & Write-off of Bad Debts | 0.16 | 0.16 | 0.38 | 0.74 | -1.36 | 0.82 | Upgrade |
Other Operating Activities | 526.74 | 57.82 | 61.84 | 54.9 | 48.66 | 20 | Upgrade |
Change in Accounts Receivable | -278.79 | -278.79 | 41.95 | -209.3 | 369.7 | -349.1 | Upgrade |
Change in Inventory | -29.72 | -29.72 | -28.46 | -10.65 | -24.04 | -32.47 | Upgrade |
Change in Accounts Payable | 75.67 | 75.67 | 9.79 | -146.43 | 136.6 | 94.45 | Upgrade |
Change in Other Net Operating Assets | - | - | 24.51 | 12.38 | -4.61 | 84.63 | Upgrade |
Operating Cash Flow | 903.9 | 456.75 | 693.41 | 285.69 | 1,035 | 237.67 | Upgrade |
Operating Cash Flow Growth | 32.22% | -34.13% | 142.72% | -72.39% | 335.44% | -41.45% | Upgrade |
Capital Expenditures | -256.53 | -255.44 | -234.81 | -272.4 | -125.57 | -339.37 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 0.04 | - | 0 | 0.31 | Upgrade |
Cash Acquisitions | - | - | - | - | -61.11 | - | Upgrade |
Investment in Securities | 37.86 | -333.78 | -354.28 | -92.56 | -1,984 | -269.25 | Upgrade |
Other Investing Activities | 79.14 | 71.21 | 278.47 | 30.46 | 14.98 | 16.41 | Upgrade |
Investing Cash Flow | -139.54 | -518.02 | -310.59 | -334.5 | -2,155 | -591.91 | Upgrade |
Long-Term Debt Issued | - | 811.87 | 750 | 806.39 | 500 | 690 | Upgrade |
Total Debt Issued | 924.2 | 811.87 | 750 | 806.39 | 500 | 690 | Upgrade |
Long-Term Debt Repaid | - | -667.63 | -961.85 | -645.26 | -347.38 | -450 | Upgrade |
Total Debt Repaid | -1,122 | -667.63 | -961.85 | -645.26 | -347.38 | -450 | Upgrade |
Net Debt Issued (Repaid) | -197.37 | 144.24 | -211.85 | 161.13 | 152.62 | 240 | Upgrade |
Issuance of Common Stock | - | - | - | - | 0.16 | 794.35 | Upgrade |
Common Dividends Paid | -398.02 | -282.45 | -220.05 | -340.51 | -195.54 | -193.19 | Upgrade |
Other Financing Activities | -2.53 | - | -0.6 | -3.84 | - | -2.16 | Upgrade |
Financing Cash Flow | -597.91 | -138.21 | -432.5 | -183.22 | -42.76 | 839.01 | Upgrade |
Foreign Exchange Rate Adjustments | 0.44 | 0.56 | 0.61 | 2.97 | -0.75 | -2.26 | Upgrade |
Net Cash Flow | 166.89 | -198.91 | -49.07 | -229.06 | -1,164 | 482.51 | Upgrade |
Free Cash Flow | 647.36 | 201.31 | 458.59 | 13.29 | 909.35 | -101.7 | Upgrade |
Free Cash Flow Growth | 51.00% | -56.10% | 3350.89% | -98.54% | - | - | Upgrade |
Free Cash Flow Margin | 27.25% | 8.61% | 22.42% | 0.65% | 51.36% | -6.85% | Upgrade |
Free Cash Flow Per Share | 1.22 | 0.38 | 0.86 | 0.03 | 1.72 | -0.19 | Upgrade |
Cash Income Tax Paid | 327.24 | 333.34 | 284.33 | 243.7 | 270.37 | 255.79 | Upgrade |
Levered Free Cash Flow | 292.68 | -157.18 | 457.62 | -2.83 | 576.99 | -360.91 | Upgrade |
Unlevered Free Cash Flow | 334.67 | -121.06 | 497.04 | 32.43 | 610.38 | -346.97 | Upgrade |
Change in Net Working Capital | -109.35 | 341.82 | -343.48 | 112.2 | -402.87 | 281.36 | Upgrade |
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.